Literature DB >> 19756360

Expression and characterization of HPV-16 L1 capsid protein in Pichia pastoris.

Silvia Boschi Bazan1, Agtha de Alencar Muniz Chaves, Karina Araújo Aires, Aurora Marques Cianciarullo, Robert L Garcea, Paulo Lee Ho.   

Abstract

Human papillomaviruses (HPVs) are responsible for the most common human sexually transmitted viral infections. Infection with high-risk HPVs, particularly HPV16, is associated with the development of cervical cancer. The papillomavirus L1 major capsid protein, the basis of the currently marketed vaccines, self-assembles into virus-like particles (VLPs). Here, we describe the expression, purification and characterization of recombinant HPV16 L1 produced by a methylotrophic yeast. A codon-optimized HPV16 L1 gene was cloned into a non-integrative expression vector under the regulation of a methanol-inducible promoter and used to transform competent Pichia pastoris cells. Purification of L1 protein from yeast extracts was performed using heparin-sepharose chromatography, followed by a disassembly/reassembly step. VLPs could be assembled from the purified L1 protein, as demonstrated by electron microscopy. The display of conformational epitopes on the VLPs surface was confirmed by hemagglutination and hemagglutination inhibition assays and by immuno-electron microscopy. This study has implications for the development of an alternative platform for the production of a papillomavirus vaccine that could be provided by public health programs, especially in resource-poor areas, where there is a great demand for low-cost vaccines.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19756360      PMCID: PMC3817616          DOI: 10.1007/s00705-009-0484-8

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  52 in total

1.  Production of human papillomavirus type 16 L1 virus-like particles by recombinant Lactobacillus casei cells.

Authors:  Karina Araujo Aires; Aurora Marques Cianciarullo; Sylvia Mendes Carneiro; Luisa Lina Villa; Enrique Boccardo; Gaspar Pérez-Martinez; Isabel Perez-Arellano; Maria Leonor Sarno Oliveira; Paulo Lee Ho
Journal:  Appl Environ Microbiol       Date:  2006-01       Impact factor: 4.792

2.  Disassembly and reassembly of yeast-derived recombinant human papillomavirus virus-like particles (HPV VLPs).

Authors:  Henryk Mach; David B Volkin; Robert D Troutman; Bei Wang; Zheng Luo; Kathrin U Jansen; Li Shi
Journal:  J Pharm Sci       Date:  2006-10       Impact factor: 3.534

3.  Papillomavirus capsid protein expression in Escherichia coli: purification and assembly of HPV11 and HPV16 L1.

Authors:  X S Chen; G Casini; S C Harrison; R L Garcea
Journal:  J Mol Biol       Date:  2001-03-16       Impact factor: 5.469

4.  Expression of human papillomavirus type 16 L1 protein in Escherichia coli: denaturation, renaturation, and self-assembly of virus-like particles in vitro.

Authors:  W Zhang; J Carmichael; J Ferguson; S Inglis; H Ashrafian; M Stanley
Journal:  Virology       Date:  1998-04-10       Impact factor: 3.616

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Construction of prophylactic human papillomavirus type 16 L1 capsid protein vaccine delivered by live attenuated Shigella flexneri strain sh42.

Authors:  Xiao-Feng Yang; Xin-Zhong Qu; Kai Wang; Jin Zheng; Lü-Sheng Si; Xiao-Ping Dong; Yi-Li Wang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2005-11       Impact factor: 3.848

7.  Human papillomavirus type 11 recombinant L1 capsomeres induce virus-neutralizing antibodies.

Authors:  R C Rose; W I White; M Li; J A Suzich; C Lane; R L Garcea
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

8.  Optimum conditions for production and purification of human papillomavirus type 16 L1 protein from Saccharomyces cerevisiae.

Authors:  Min-A Park; Hyoung Jin Kim; Hong-Jin Kim
Journal:  Protein Expr Purif       Date:  2008-02-15       Impact factor: 1.650

9.  Expression of the major capsid protein of human papillomavirus type 16 in Escherichia coli.

Authors:  S R Kelsall; J K Kulski
Journal:  J Virol Methods       Date:  1995-05       Impact factor: 2.014

Review 10.  Recombinant protein expression in Pichia pastoris.

Authors:  J M Cregg; J L Cereghino; J Shi; D R Higgins
Journal:  Mol Biotechnol       Date:  2000-09       Impact factor: 2.860

View more
  14 in total

1.  Whole recombinant Pichia pastoris expressing HPV16 L1 antigen is superior in inducing protection against tumor growth as compared to killed transgenic Leishmania.

Authors:  Azam Bolhassani; Martin Muller; Farzin Roohvand; Fatemeh Motevalli; Elnaz Agi; Mehdi Shokri; Mahdieh Motamedi Rad; Sahar Hosseinzadeh
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

2.  Expression of codon optimized major capsid protein (L1) of human papillomavirus type 16 and 18 in Pichia pastoris; purification and characterization of the virus-like particles.

Authors:  N Hanumantha Rao; P Baji Babu; L Rajendra; R Sriraman; Yuk-Ying S Pang; John T Schiller; V A Srinivasan
Journal:  Vaccine       Date:  2011-07-29       Impact factor: 3.641

Review 3.  Recent advances in the production of recombinant subunit vaccines in Pichia pastoris.

Authors:  Man Wang; Shuai Jiang; Yefu Wang
Journal:  Bioengineered       Date:  2016-04       Impact factor: 3.269

4.  Expression, purification and characterization of low-glycosylation influenza neuraminidase in α-1,6-mannosyltransferase defective Pichia pastoris.

Authors:  Yi-Li Yang; Shao-Hong Chang; Xin Gong; Jun Wu; Bo Liu
Journal:  Mol Biol Rep       Date:  2011-05-13       Impact factor: 2.316

Review 5.  New approaches to prophylactic human papillomavirus vaccines for cervical cancer prevention.

Authors:  Elizabeth D Gersch; Lutz Gissmann; Robert L Garcea
Journal:  Antivir Ther       Date:  2011-11-07

6.  Development of an IP-Free Biotechnology Platform for Constitutive Production of HPV16 L1 Capsid Protein Using the Pichia pastoris PGK1 Promoter.

Authors:  F C Mariz; E C Coimbra; A L S Jesus; L M Nascimento; F A G Torres; A C Freitas
Journal:  Biomed Res Int       Date:  2015-05-18       Impact factor: 3.411

Review 7.  Applications of recombinant Pichia pastoris in the healthcare industry.

Authors:  Daniel Weinacker; Claudia Rabert; Andrea B Zepeda; Carolina A Figueroa; Adalberto Pessoa; Jorge G Farías
Journal:  Braz J Microbiol       Date:  2014-03-10       Impact factor: 2.476

8.  Expression and Characterization of Yeast Derived Chikungunya Virus Like Particles (CHIK-VLPs) and Its Evaluation as a Potential Vaccine Candidate.

Authors:  Shweta Saraswat; T N Athmaram; Manmohan Parida; Ankita Agarwal; Amrita Saha; Paban Kumar Dash
Journal:  PLoS Negl Trop Dis       Date:  2016-07-11

Review 9.  Human papilloma virus in oral cancer.

Authors:  Soung Min Kim
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2016-12-27

Review 10.  Current status of human papillomavirus vaccines.

Authors:  Kwang Sung Kim; Shin Ae Park; Kyung-Nam Ko; Seokjae Yi; Yang Je Cho
Journal:  Clin Exp Vaccine Res       Date:  2014-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.